PubMed for id: 1445144634

Year	Number of Results
1991	3
1992	1
2004	1
2023	4
2024	3

1

Genetic variation of CYP2C9 gene and its correlation with cardiovascular disease risk factors.

Rasool GS, Al-Awadi SJ, Hussien AA, Al-Attar MM. Rasool GS, et al. Mol Biol Rep. 2024 Jan 16;51(1):105. doi: 10.1007/s11033-023-09151-4. Mol Biol Rep. 2024. PMID: 38227154

2

Association of variants in the ABCB1, CYP2C19 and CYP2C9 genes for Juvenile Myoclonic Epilepsy.

Jara-Prado A, Guerrero-Camacho JL, Ángeles-López QD, Ochoa-Morales A, Dávila-Ortiz de Montellano DJ, Ramírez-García MÁ, Breda-Yepes M, Durón RM, Delgado-Escueta AV, Barrios-González DA, Martínez-Juárez IE. Jara-Prado A, et al. Neurol Sci. 2024 Apr;45(4):1635-1643. doi: 10.1007/s10072-023-07124-w. Epub 2023 Oct 25. Neurol Sci. 2024. PMID: 37875597

3

Impact of CYP2C9*2 and *3 polymorphisms on valproate-associated adverse drug reactions in individuals living with epilepsy: a case-control study.

Ramakrishnan K, Kesavan R, Venkatraman S, Narayan SK, Kumar RR, Shewade D. Ramakrishnan K, et al. Per Med. 2023 Sep;20(5):417-424. doi: 10.2217/pme-2023-0033. Epub 2023 Oct 9. Per Med. 2023. PMID: 37811569

4

Identification of the effects of pathogenic genetic variations of human CYP2C9 and CYP2D6: an in silico approach.

Avsar O. Avsar O. Nucleosides Nucleotides Nucleic Acids. 2024;43(4):356-376. doi: 10.1080/15257770.2023.2262519. Epub 2023 Sep 25. Nucleosides Nucleotides Nucleic Acids. 2024. PMID: 37747773

5

Effects of CYP3A4 and CYP2C9 genotype on systemic anastrozole and fulvestrant concentrations in SWOG S0226.

Rutherford DV, Medley S, Henderson NC, Gersch CL, Vandenberg TA, Albain KS, Dakhil SR, Tirumali NR, Gralow JR, Hortobagyi GN, Pusztai L, Mehta RS, Hayes DF, Kidwell KM, Henry NL, Barlow WE, Rae JM, Hertz DL. Rutherford DV, et al. Pharmacogenomics. 2023 Aug;24(12):665-673. doi: 10.2217/pgs-2023-0097. Epub 2023 Aug 24. Pharmacogenomics. 2023. PMID: 37615099

6

Comparison of cytochrome P450 (CYP) genes from the mouse and human genomes, including nomenclature recommendations for genes, pseudogenes and alternative-splice variants.

Nelson DR, Zeldin DC, Hoffman SM, Maltais LJ, Wain HM, Nebert DW. Nelson DR, et al. Pharmacogenetics. 2004 Jan;14(1):1-18. doi: 10.1097/00008571-200401000-00001. Pharmacogenetics. 2004. PMID: 15128046 Review.

7

Tolbutamide and phenytoin hydroxylations by cDNA-expressed human liver cytochrome P4502C9.

Veronese ME, Mackenzie PI, Doecke CJ, McManus ME, Miners JO, Birkett DJ. Veronese ME, et al. Biochem Biophys Res Commun. 1991 Mar 29;175(3):1112-8. doi: 10.1016/0006-291x(91)91680-b. Biochem Biophys Res Commun. 1991. PMID: 2025243

8

Cloning and expression of complementary DNAs for multiple members of the human cytochrome P450IIC subfamily.

Romkes M, Faletto MB, Blaisdell JA, Raucy JL, Goldstein JA. Romkes M, et al. Biochemistry. 1991 Apr 2;30(13):3247-55. doi: 10.1021/bi00227a012. Biochemistry. 1991. PMID: 2009263

9

Separation of human liver microsomal tolbutamide hydroxylase and (S)-mephenytoin 4'-hydroxylase cytochrome P-450 enzymes.

Srivastava PK, Yun CH, Beaune PH, Ged C, Guengerich FP. Srivastava PK, et al. Mol Pharmacol. 1991 Jul;40(1):69-79. Mol Pharmacol. 1991. PMID: 1857342

10

Six-base deletion occurring in messages of human cytochrome P-450 in the CYP2C subfamily results in reduction of tolbutamide hydroxylase activity.

Ohgiya S, Komori M, Ohi H, Shiramatsu K, Shinriki N, Kamataki T. Ohgiya S, et al. Biochem Int. 1992 Sep;27(6):1073-81. Biochem Int. 1992. PMID: 1445376

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

10 results

Results by year